{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:34:28Z","timestamp":1783110868003,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union","award":["DTS22\/00048"],"award-info":[{"award-number":["DTS22\/00048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The tumor microenvironment (TME) plays a critical role in cancer progression and response to treatment. In colorectal cancer (CRC), a collagen-rich extracellular matrix (ECM) is a well-established feature of primary tumors and liver metastases. However, the composition of the ECM in peritoneal metastases remains poorly characterized. In this descriptive study, we analyzed the histological distribution of four major collagen types (I, II, III, and IV) in peritoneal metastases from 39 CRC patients using immunohistochemical techniques. Type III fibrillar collagen was predominant, showing moderate to high expression in 80 percent of cases, followed by type IV collagen in 56 percent. Type I collagen demonstrated low intensity in 64 percent of cases. Notably, type\u202fII collagen, typically restricted to cartilaginous tissues, was also detected within the tumor stroma, an unexpected finding given its usual absence in this histological contex. These results highlight the unique collagen-rich stroma in CRC peritoneal metastases, dominated by types III and IV collagen, and identify type II collagen as a novel component. This study provides new insight into the stromal architecture of CRC peritoneal metastases and may serve as a foundation for future research on collagen-targeted therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41598-025-05604-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:17:16Z","timestamp":1751375836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterization of collagen profile in peritoneal metastases of colorectal cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"P.","family":"Villarejo-Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Garc\u00eda","family":"G\u00f3mez-Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gonz\u00e1lez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Qian Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Franco-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"D\u00edaz-Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Olivera-Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Garc\u00eda-Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00eda-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5604_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias, D. et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J. Clin. Oncol. 27, 681\u2013685 (2009).","journal-title":"J. Clin. Oncol."},{"key":"5604_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1245\/s10434-018-6860-4","volume":"26","author":"Y Feferman","year":"2019","unstructured":"Feferman, Y. et al. Sites of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis from colorectal and appendiceal adenocarcinoma: A tertiary center experience. Ann Surg Oncol 26, 482\u2013489 (2019).","journal-title":"Ann Surg Oncol"},{"key":"5604_CR3","doi-asserted-by":"crossref","unstructured":"Sommariva, A. et al. Colorectal Cancer with peritoneal metastases: The Impact of the results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on peritoneal disease management. Cancers (Basel) 15, 165 (2022).","DOI":"10.3390\/cancers15010165"},{"key":"5604_CR4","doi-asserted-by":"crossref","unstructured":"Graf, W., Ghanipour, L., Birgisson, H. & Cashin, P. H. Cytoreductive Surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases from colorectal c\u00e1ncer: An overview of current status and future perspectives. Cancers (Basel) 16, 284 (2024).","DOI":"10.3390\/cancers16020284"},{"key":"5604_CR5","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Olmo, D. et al. Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis. Sci. Rep. 11 (2021).","DOI":"10.1038\/s41598-020-79721-0"},{"key":"5604_CR6","doi-asserted-by":"crossref","unstructured":"Alipour, H., Raz, A., Zakeri, S. & Dinparast Djadid, N. Therapeutic applications of collagenase (metalloproteases): A review. Asian Pac. J. Trop. Biomed. 6, 975\u2013981 (2016).","DOI":"10.1016\/j.apjtb.2016.07.017"},{"key":"5604_CR7","doi-asserted-by":"publisher","first-page":"a004978","DOI":"10.1101\/cshperspect.a004978","volume":"3","author":"S Ricard-Blum","year":"2011","unstructured":"Ricard-Blum, S. The collagen family. Cold Spring Harb Perspect Biol 3, a004978\u2013a004978 (2011).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5604_CR8","doi-asserted-by":"crossref","unstructured":"Elango, J. et al. The molecular interaction of collagen with cell receptors for biological function. Polymers (Basel) 14, 876 (2022).","DOI":"10.3390\/polym14050876"},{"key":"5604_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-22-2034","volume":"83","author":"D De Martino","year":"2023","unstructured":"De Martino, D. & Bravo-Cordero, J. J. Collagens in cancer: Structural regulators and guardians of cancer progression. Cancer Res 83, 1386\u20131392 (2023).","journal-title":"Cancer Res"},{"key":"5604_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","volume":"3","author":"JS Di Martino","year":"2022","unstructured":"Di Martino, J. S. et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer 3, 90\u2013107 (2022).","journal-title":"Nat Cancer"},{"key":"5604_CR11","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1038\/s44319-024-00180-z","volume":"25","author":"L Ippolito","year":"2024","unstructured":"Ippolito, L. et al. Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer. EMBO Rep 25, 3506\u20133531 (2024).","journal-title":"EMBO Rep"},{"key":"5604_CR12","doi-asserted-by":"crossref","unstructured":"Zhao, Q. & Liu, J. P4HA1, a Prognostic biomarker that correlates with immune infiltrates in lung adenocarcinoma and pan-cancer. Front Cell Dev Biol 9, (2021).","DOI":"10.3389\/fcell.2021.754580"},{"key":"5604_CR13","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","volume":"55","author":"K Gelse","year":"2003","unstructured":"Gelse, K. Collagens\u2014structure, function, and biosynthesis. Adv Drug Deliv Rev 55, 1531\u20131546 (2003).","journal-title":"Adv Drug Deliv Rev"},{"key":"5604_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/110241598750004274","volume":"164","author":"M Hilska","year":"2003","unstructured":"Hilska, M. et al. The distribution of collagen types I, III, and IV in normal and malignant colorectal mucosa. Eur. J. Surg. 164, 457\u2013464 (2003).","journal-title":"Eur. J. Surg."},{"key":"5604_CR15","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1016\/j.bpj.2021.08.013","volume":"120","author":"A Al-Shaer","year":"2021","unstructured":"Al-Shaer, A. et al. Sequence-dependent mechanics of collagen reflect its structural and functional organization. Biophys J 120, 4013\u20134028 (2021).","journal-title":"Biophys J"},{"key":"5604_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1071-5576(01)00122-8","volume":"8","author":"C Witz","year":"2001","unstructured":"Witz, C. Composition of the extracellular matrix of the peritoneum. J Soc Gynecol Investig 8, 299\u2013304 (2001).","journal-title":"J Soc Gynecol Investig"},{"key":"5604_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu, S. et al. The role of collagen in cancer: From bench to bedside. J Transl Med 17, 309 (2019).","journal-title":"J Transl Med"},{"key":"5604_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/bioengineering8020017","volume":"8","author":"JN Ouellette","year":"2021","unstructured":"Ouellette, J. N. et al. Navigating the collagen jungle: the biomedical potential of fiber organization in cancer. Bioengineering 8, 17 (2021).","journal-title":"Bioengineering"},{"key":"5604_CR19","doi-asserted-by":"crossref","unstructured":"Lindgren, M. et al. Type IV Collagen in human colorectal liver metastases-cellular origin and a circulating biomarker. Cancers (Basel) 14 (2022).","DOI":"10.3390\/cancers14143396"},{"key":"5604_CR20","doi-asserted-by":"publisher","first-page":"103269","DOI":"10.1016\/j.ebiom.2021.103269","volume":"65","author":"P Micke","year":"2021","unstructured":"Micke, P. et al. The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types. EBioMedicine 65, 103269 (2021).","journal-title":"EBioMedicine"},{"key":"5604_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes, R. M. et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J. Thorac. Oncol. 6, 209\u2013217 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"5604_CR22","doi-asserted-by":"publisher","first-page":"e240407","DOI":"10.1001\/jamanetworkopen.2024.0407","volume":"7","author":"E Lou","year":"2024","unstructured":"Lou, E. et al. Tumor-stroma proportion to predict chemoresistance in patients with ovarian cancer. JAMA Netw Open 7, e240407 (2024).","journal-title":"JAMA Netw Open"},{"key":"5604_CR23","doi-asserted-by":"publisher","first-page":"115390","DOI":"10.1016\/j.biopha.2023.115390","volume":"166","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q., An, Z.-Y., Jiang, W., Jin, W.-L. & He, X.-Y. Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications. Biomed. Pharmacother. 166, 115390 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"5604_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7729","author":"Y Liang","year":"2020","unstructured":"Liang, Y. et al. Prognostic significance of abnormal matrix collagen remodeling in colorectal cancer based on histologic and bioinformatics analysis. Oncol Rep https:\/\/doi.org\/10.3892\/or.2020.7729 (2020).","journal-title":"Oncol Rep"},{"key":"5604_CR25","doi-asserted-by":"crossref","unstructured":"Le, C. C. et al. Functional interplay between collagen network and cell behavior within tumor microenvironment in colorectal cancer. Front. Oncol. 10, (2020).","DOI":"10.3389\/fonc.2020.00527"},{"key":"5604_CR26","doi-asserted-by":"crossref","unstructured":"Lindgren, M. et al. Type IV collagen in human colorectal liver metastases\u2014cellular origin and a circulating biomarker. Cancers (Basel) 14, 3396 (2022).","DOI":"10.3390\/cancers14143396"},{"key":"5604_CR27","first-page":"100030","volume":"4","author":"Z Wu","year":"2021","unstructured":"Wu, Z., Korntner, S., Mullen, A. & Zeugolis, D. Collagen type II: From biosynthesis to advanced biomaterials for cartilage engineering. Biomater. Biosyst. 4, 100030 (2021).","journal-title":"Biomater. Biosyst."},{"key":"5604_CR28","doi-asserted-by":"publisher","first-page":"20806","DOI":"10.1074\/jbc.M110.118521","volume":"285","author":"Z Wang","year":"2010","unstructured":"Wang, Z., Bryan, J., Franz, C., Havlioglu, N. & Sandell, L. J. Type IIB Procollagen nh2-propeptide induces death of tumor cells via interaction with integrins \u03b1V\u03b23 and \u03b1V\u03b25. J. Biol. Chem. 285, 20806\u201320817 (2010).","journal-title":"J. Biol. Chem."},{"key":"5604_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43018-021-00323-4","volume":"3","author":"B Leitinger","year":"2022","unstructured":"Leitinger, B. Pulling the strings of tumor collagen. Nat Cancer 3, 9\u201310 (2022).","journal-title":"Nat Cancer"},{"key":"5604_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10585-021-10082-2","volume":"38","author":"M Lindgren","year":"2021","unstructured":"Lindgren, M. et al. Type IV collagen as a potential biomarker of metastatic breast cancer. Clin Exp Metastasis 38, 175\u2013185 (2021).","journal-title":"Clin Exp Metastasis"},{"key":"5604_CR31","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.7150\/ijbs.21230","volume":"13","author":"B Wei","year":"2017","unstructured":"Wei, B. et al. Human colorectal cancer progression correlates with LOX-induced ECM stiffening. Int J Biol Sci 13, 1450\u20131457 (2017).","journal-title":"Int J Biol Sci"},{"key":"5604_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11010-015-2384-4","volume":"404","author":"R Huang","year":"2015","unstructured":"Huang, R., Huang, D., Dai, W. & Yang, F. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer. Mol Cell Biochem 404, 251\u2013257 (2015).","journal-title":"Mol Cell Biochem"},{"key":"5604_CR33","doi-asserted-by":"crossref","unstructured":"Brown, L. D., Cai, T. T. & DasGupta, A. Interval estimation for a binomial proportion. Stat. Sci. 16, (2001).","DOI":"10.1214\/ss\/1009213286"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05604-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05604-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05604-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:17:20Z","timestamp":1751375840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05604-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5604"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05604-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Clinical Research Ethics Committee (CEIC) under code PIC_003-21_FJD. The CEIC, in both its composition and its standard processes, complies with the necessary standards (CPMP\/ICH\/135\/95) and with Order SAS 3470\/2009 of December 16. All collected data were anonymized to prevent patient identification, in accordance with European and national legislation (Regulation (EU) 2016\/679 and Organic Law 7\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"20528"}}